Peripheral Arterial Disease (PAD)

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD).

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA...
IN.PACT Admiral, Global Study, DEB SFA-LONG, long peripheral lesions, EuroPCR
New clinical data from two different studies show the IN.PACT Admiral drug-coated balloon from Medtronic plc successfully treated long lesions in the...
Stellarex, Spectranetics, investment, BTK, peripheral artery disease
The Spectranetics Corporation announced it is accelerating investments in the Stellarex drug-coated balloon angioplasty (DCB) platform for treatment of below...
Boston Scientific, Eluvia, MAJESTIC trial, vascular stent, PAD
A key trial evaluating the Boston Scientific Eluvia drug-eluting vascular stent system met its primary endpoint, with more than 94 percent of the lesions...
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon
Medtronic’s In.Pact Admiral drug-coated balloon (DCB) is for the interventional treatment of peripheral artery disease (PAD) for the
The RadAR vascular compression device from Advanced Vascular Dynamics is specified for post-procedure hemostasis of tibiopedal access...
The SpeX shapeable support catheter from ReFlow Medical Inc. enables physicians to shape the tip of the support catheter to their preferred...

Articles

Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA...
Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $...
Hielscher, Columbia, PAD, OCT, diabetes, optical tomographic imaging, peripheral
Approximately 8 to 12 million people in the United States alone are suffering from peripheral arterial disease (PAD), a common vascular problem that is also...
Medtronic, In.Pact Admiral DEB, drug coated balloon, drug eluting balloon
Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease...

Video Center

There were several technology takeaway messages for the future of electrophysiology (EP) at the...
5 days 6 hours ago
The Heart Rhythm Society’s 36th Annual Scientific Sessions, May 13-16, 2015 in Boston, will offer...
2 weeks 2 days ago
U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
4 weeks 6 days ago
The webinar Maximize Your Clinical Imaging With a VNA Strategy will explain the changing face of medical imaging and data, and the challenges to...
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...

Comparison Charts

Sorry there is no data available